3-139518422-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_002899.5(RBP1):āc.539T>Cā(p.Leu180Pro) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000589 in 1,613,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_002899.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RBP1 | NM_002899.5 | c.539T>C | p.Leu180Pro | missense_variant, splice_region_variant | 3/4 | ENST00000672186.1 | |
COPB2-DT | NR_121609.1 | n.355-59370A>G | intron_variant, non_coding_transcript_variant | ||||
RBP1 | NM_001365940.2 | c.353T>C | p.Leu118Pro | missense_variant, splice_region_variant | 3/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RBP1 | ENST00000672186.1 | c.539T>C | p.Leu180Pro | missense_variant, splice_region_variant | 3/4 | NM_002899.5 | |||
COPB2-DT | ENST00000658348.1 | n.672-59370A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152138Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000327 AC: 82AN: 250920Hom.: 0 AF XY: 0.000347 AC XY: 47AN XY: 135590
GnomAD4 exome AF: 0.000621 AC: 907AN: 1461600Hom.: 0 Cov.: 30 AF XY: 0.000638 AC XY: 464AN XY: 727102
GnomAD4 genome AF: 0.000289 AC: 44AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 16, 2021 | The c.539T>C (p.L180P) alteration is located in exon 3 (coding exon 3) of the RBP1 gene. This alteration results from a T to C substitution at nucleotide position 539, causing the leucine (L) at amino acid position 180 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 180 of the RBP1 protein (p.Leu180Pro). This variant is present in population databases (rs145071297, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with RBP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1451081). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at